UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

Position in BVS — Bioventus Inc.

CIK 861177 NEW YORK, NY

Back to BVS Full portfolio

Position in BVS

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$6,947

+$228 QoQ

Shares Held

736

0.0% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#129

of 155 holders

Holding Since

Jun 2021

8 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Common Shares in BVS Over Time

Shares Held

Position Value (USD)

Position in Medical Devices

Healthcare · as of Jun 30, 2026

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,740,663,804 across 61 Medical Devices names. BVS ranks #51 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABT	Abbott Laboratories	12,835,753	$1,164,716,222
2	SYK	Stryker Corp	2,689,376	$846,723,135
3	DXCM	Dexcom Inc	11,261,876	$758,487,343
4	BSX	Boston Scientific Corp	13,091,481	$558,744,402
5	EW	Edwards Lifesciences Corp	5,488,643	$496,502,640
6	GEHC	GE HealthCare Technologies Inc.	2,541,393	$162,674,562
7	ZBH	Zimmer Biomet Holdings, Inc.	1,457,553	$125,480,733
8	BIO	Bio-Rad Laboratories, Inc.	418,884	$122,988,525

All Filings in BVS

Export CSV

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$6,947	736	0.0%	Shares	Defined	2026-08-13
2026-03-31	$6,719	736	-99.5%	Shares	Defined	2026-05-13
2025-06-30	$956,159	144,435	+81.7%	Shares	Defined	2025-08-14
2025-03-31	$727,414	79,499	+22.0%	Shares	Defined	2025-05-19
2024-12-31	$684,127	65,155	+17.4%	Shares	Defined	2025-02-14
2022-12-31	$144,883	55,511	-85.7%	Shares	Sole	2023-02-14
2021-09-30	$5,501,626	388,533	-2.8%	Shares	Defined	2021-11-15
2021-06-30	$7,036,971	399,828	—	Shares	Defined	2021-08-16
No filing history on record for this holder in this stock.